20.10SEK-0.50%Mkt Cap: 1.33B SEKP/E: 54.32Last update: 2026-06-01
Genovis AB (publ.) develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia. The company provides FabRICATOR, FabALACTICA, FabRICATOR Z, GingisKHAN, FabULOU…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.33B SEK
Enterprise Value1.24B SEK
Revenue (TTM)131.09M SEK
Gross Profit115.85M SEK
Net Income (TTM)23.50M SEK
Revenue/Share1.988 SEK
Last Price20.10 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees36
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0002485979
Valuation
P/E (Trailing)54.32
P/E (Forward)42.98
PEG—
EV/EBITDA40.39
EV/Revenue9.43
P/S10.18
P/B4.81
EPS (TTM)0.37
EPS (Forward)0.47
52W Range
15.6431% of range29.80
52W High29.80 SEK
52W Low15.64 SEK
Profitability
Gross Margin89.85%
Oper. Margin15.78%
EBITDA Margin23.36%
Profit Margin18.22%
ROE8.65%
ROA6.22%
Growth
Revenue Growth3.50%
Earnings Growth22.10%
Cash Flow & Leverage
Operating CF32.02M SEK
CapEx (TTM)12.52M SEK
FCF Margin6.60%
FCF Yield0.65%
Net Debt-97.92M SEK
Net Debt/EBITDA-3.20
Balance Sheet
Debt/Equity0.27
Current Ratio7.65
Quick Ratio6.14
Book Value/Sh4.198 SEK
Cash/Share2.587 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 4, 2012
Analyst Consensus
Rating—
Target (Mean)32.67 SEK
Target Range27.00 SEK – 41.00 SEK
# Analysts3
Ownership
Shares Out.66.06M
Float55.20M
Insiders18.22%
Institutions36.61%
Technical
SMA 5019.47 (+3.2%)
SMA 20020.61 (-2.5%)
Beta1.70
S&P 52W Chg27.70%
Avg Vol (30d)60.40K
Avg Vol (10d)64.71K
Technical Indicators
RSI (14)52.4
MACD0.1451
MACD Signal0.2421
MACD Hist.-0.0971
BB Upper21.07 SEK
BB Middle20.14 SEK
BB Lower19.20 SEK
BB Width9.31%
ATR (14)0.9463 SEK
Vol Ratio (20d)1.08x